News

Video

Moonshot Cancer Initiative and MCED Consortium: Advancing Cancer Detection

Author(s):

Elizabeth O’Donnell, MD, Dana-Farber Cancer Institute,Jon O. Ebbert, MD, Mayo Clinic

Explore the pivotal role of the Moonshot Cancer Initiative and MCED Consortium in shaping the landscape of early cancer detection and screening, with a focus on innovative screening tools and legislative support.

Related Videos
Nancy U. Lin, MD, discusses the safety data from DESTINY-Breast12 with T-DXd for HER2+ advanced/metastatic breast cancer with or without brain metastases.
Daniel DeAngelo, MD, PhD, discusses how the shift away from chemotherapy has affected the management of chronic lymphocytic leukemia.
2 KOLs are featured in this series.
Daniel DeAngelo, MD, PhD
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
Tanios S. Bekaii-Saab, MD
November 19th 2024

Liquid Biopsies, ctDNA Could Help Guide Gastrointestinal Cancer Management

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Tanios S. Bekaii-Saab, MD
November 17th 2024

Molecular Testing Helps First-Line Treatment Landscape Evolve in Pancreatic Cancer

Narjust Florez, MD
September 5th 2024

Florez Focuses on Patient-Centered NSCLC Biomarker Testing Discussions

Shaji Kumar, MD, research chair, Division of Hematology, consultant, Division of Hematology, professor, medicine, Mayo Clinic
November 6th 2024

Notable 2024/Early 2025 Multiple Myeloma NCCN Guideline Updates Feature Quadruplets and More

Tanios S. Bekaii-Saab, MD, of Mayo Clinic
November 4th 2024

Continued Development of RAS Inhibitors Leads the Charge in Pancreatic Cancer Research